Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT03829579 Approved for marketing - Clinical trials for Depressive Disorder, Treatment-Resistant

Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)

Start date: n/a
Phase:
Study type: Expanded Access

This is a pre-approval access program (PAAP) for eligible participants. The main purpose of this program is to provide access to esketamine nasal spray to eligible participant with treatment-resistant depression (TRD), who have exhausted all other treatment options, including all alternative treatment options with marketed therapies.